• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠肺炎肺组织中巨噬细胞标志物 CD68 和 CD163、血管紧张素转化酶 2(ACE2)和半胱氨酸蛋白酶-3 的表达

Lung Expression of Macrophage Markers CD68 and CD163, Angiotensin Converting Enzyme 2 (ACE2), and Caspase-3 in COVID-19.

机构信息

Department of Pathophysiology, Bogomolets National Medical University, 01601 Kyiv, Ukraine.

Department of Internal Medicine, Corewell Health William Beaumont University Hospital, Royal Oak, MI 48073, USA.

出版信息

Medicina (Kaunas). 2023 Apr 6;59(4):714. doi: 10.3390/medicina59040714.

DOI:10.3390/medicina59040714
PMID:37109672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10144424/
Abstract

The coronavirus (SARS-CoV-2) damages all systems and organs. Yet, to a greater extent, the lungs are particularly involved, due to the formation of diffuse exudative inflammation in the form of acute respiratory distress syndrome (ARDS) with next progression to pulmonary fibrosis. SARS-associated lung damage is accompanied by the pronounced activation of mononuclear cells, damage of the alveoli and microvessels, and the development of organized pneumonia. To study the expression of macrophage markers (CD68 and CD163), angiotensin-converting enzyme-2 (ACE2), and caspase-3 on the results of two fatal clinical observations of COVID-19. In both clinical cases, the female patients died from complications of confirmed COVID-19. Conventional morphological and immunohistochemical methods were used. There was an acute exudative hemorrhagic pneumonia with the formation of hyaline membranes, focal organization of fibrin, stromal sclerosis, stasis, and thrombus formation in the lung vessels. Signs such as the formation of hyaline membranes, organization, and fibrosis were more pronounced in severe disease activity. The activation of CD68+/CD163+ macrophages could cause cell damage at an early stage of pneumonia development, and subsequently cause fibrotic changes in lung tissue. ACE2 expression in lung tissue was not detected in severe pneumonia, while in moderate pneumonia, weak expression was noted in individual cells of the alveolar epithelium and vascular endothelium. This finding could show the dependence of ACE2 expression on the severity of the inflammatory process in the lungs. The expression of caspase-3 was more pronounced in severe pneumonia.

摘要

冠状病毒(SARS-CoV-2)会损害所有系统和器官。然而,由于弥漫性渗出性炎症以急性呼吸窘迫综合征(ARDS)的形式形成,随后发展为肺纤维化,肺部受到的影响更大。与 SARS 相关的肺部损伤伴随着单核细胞的显著激活、肺泡和微血管的损伤以及机化性肺炎的发展。为了研究巨噬细胞标志物(CD68 和 CD163)、血管紧张素转换酶 2(ACE2)和半胱氨酸蛋白酶-3 在 2 例 COVID-19 致命临床观察结果中的表达。在这 2 例临床病例中,女性患者均因确诊 COVID-19 的并发症而死亡。采用常规形态学和免疫组织化学方法。肺组织中存在急性渗出性出血性肺炎,形成透明膜,局灶性纤维蛋白组织,基质硬化,停滞和血管内血栓形成。在严重疾病活动期,透明膜形成、组织化和纤维化等迹象更为明显。CD68+/CD163+巨噬细胞的激活可能导致肺炎发展早期的细胞损伤,随后导致肺组织纤维化改变。在严重肺炎中未检测到肺组织中 ACE2 的表达,而在中度肺炎中,仅在肺泡上皮和血管内皮的个别细胞中观察到弱表达。这一发现表明 ACE2 的表达依赖于肺部炎症过程的严重程度。半胱氨酸蛋白酶-3 在严重肺炎中的表达更为明显。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d31/10144424/cae1a6664320/medicina-59-00714-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d31/10144424/72339e17c101/medicina-59-00714-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d31/10144424/090dbd7f029f/medicina-59-00714-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d31/10144424/7285584971cf/medicina-59-00714-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d31/10144424/15162ff0a6ff/medicina-59-00714-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d31/10144424/089f09f57a8c/medicina-59-00714-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d31/10144424/cae1a6664320/medicina-59-00714-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d31/10144424/72339e17c101/medicina-59-00714-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d31/10144424/090dbd7f029f/medicina-59-00714-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d31/10144424/7285584971cf/medicina-59-00714-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d31/10144424/15162ff0a6ff/medicina-59-00714-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d31/10144424/089f09f57a8c/medicina-59-00714-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d31/10144424/cae1a6664320/medicina-59-00714-g006.jpg

相似文献

1
Lung Expression of Macrophage Markers CD68 and CD163, Angiotensin Converting Enzyme 2 (ACE2), and Caspase-3 in COVID-19.新冠肺炎肺组织中巨噬细胞标志物 CD68 和 CD163、血管紧张素转化酶 2(ACE2)和半胱氨酸蛋白酶-3 的表达
Medicina (Kaunas). 2023 Apr 6;59(4):714. doi: 10.3390/medicina59040714.
2
ACE2 protein expression in lung tissues of severe COVID-19 infection.严重 COVID-19 感染肺组织中的 ACE2 蛋白表达。
Sci Rep. 2022 Mar 8;12(1):4058. doi: 10.1038/s41598-022-07918-6.
3
Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19-related Acute Respiratory Distress Syndrome.COVID-19 相关急性呼吸窘迫综合征中血管紧张素转换酶 2 的增加和肺泡 II 型细胞的丢失。
Am J Respir Crit Care Med. 2021 Nov 1;204(9):1024-1034. doi: 10.1164/rccm.202012-4461OC.
4
Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19.代谢相关脂肪性肝病及致死性 COVID-19 患者肝组织血管紧张素转换酶 2 的表达。
World J Gastroenterol. 2024 Aug 21;30(31):3705-3716. doi: 10.3748/wjg.v30.i31.3705.
5
Involvement of the ACE2/Ang-(1-7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19.ACE2/Ang-(1-7)/MasR 轴在肺纤维化中的作用:对 COVID-19 的影响。
Int J Mol Sci. 2021 Nov 30;22(23):12955. doi: 10.3390/ijms222312955.
6
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
7
The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities.血管紧张素转换酶2(ACE2)在新型冠状病毒肺炎及基础合并症治疗中的双向开关作用
Molecules. 2020 Dec 31;26(1):142. doi: 10.3390/molecules26010142.
8
Putative mechanism of neurological damage in COVID-19 infection.新冠病毒感染导致神经损伤的推测机制。
Acta Neurobiol Exp (Wars). 2021;81(1):69-79. doi: 10.21307/ane-2021-008.
9
Comparative analysis of ACE2 protein expression in rodent, non-human primate, and human respiratory tract at baseline and after injury: A conundrum for COVID-19 pathogenesis.在基础状态和损伤后,对啮齿动物、非人类灵长类动物和人类呼吸道中 ACE2 蛋白表达的比较分析:COVID-19 发病机制的难题。
PLoS One. 2021 Feb 24;16(2):e0247510. doi: 10.1371/journal.pone.0247510. eCollection 2021.
10
[A pathological report of three COVID-19 cases by minimal invasive autopsies].[三例新冠病毒病病例微创尸检病理报告]
Zhonghua Bing Li Xue Za Zhi. 2020 May 8;49(5):411-417. doi: 10.3760/cma.j.cn112151-20200312-00193.

引用本文的文献

1
SARS-CoV-2 XBB.1.5 infects wild-type C57BL/6 mice and induces a protective CD4 T cell response required for viral clearance.严重急性呼吸综合征冠状病毒2型XBB.1.5感染野生型C57BL/6小鼠,并诱导病毒清除所需的保护性CD4 T细胞反应。
Front Cell Infect Microbiol. 2025 Aug 1;15:1621226. doi: 10.3389/fcimb.2025.1621226. eCollection 2025.
2
Cross protection to SARS-CoV-2 variants in hamsters with naturally-acquired immunity.自然获得性免疫对仓鼠中 SARS-CoV-2 变体的交叉保护。
Virol J. 2023 Jul 28;20(1):167. doi: 10.1186/s12985-023-02136-6.
3
Differential Gene Expression of SARS-CoV-2 Positive Bronchoalveolar Lavages: A Case Series.

本文引用的文献

1
Immune Response Gaps Linked to SARS-CoV-2 Infection: Cellular Exhaustion, Senescence, or Both?免疫反应缺陷与 SARS-CoV-2 感染相关:细胞耗竭、衰老,还是两者皆有?
Int J Mol Sci. 2022 Nov 8;23(22):13734. doi: 10.3390/ijms232213734.
2
[A new approach to combat the sepsis including COVID-19 by accelerating detoxification of hemolysis-related DAMPs].一种通过加速与溶血相关的损伤相关分子模式的解毒来对抗包括新冠肺炎在内的脓毒症的新方法
Nihon Yakurigaku Zasshi. 2022;157(6):422-425. doi: 10.1254/fpj.22073.
3
Insights from Transcriptomics: CD163 Profibrotic Lung Macrophages in COVID-19.
SARS-CoV-2 阳性支气管肺泡灌洗液的差异基因表达:一项病例系列研究。
Pathobiology. 2024;91(2):158-168. doi: 10.1159/000532057. Epub 2023 Jul 25.
转录组学研究的新发现:COVID-19 中 CD163 阳性致肺纤维化的巨噬细胞。
Am J Respir Cell Mol Biol. 2022 Nov;67(5):520-527. doi: 10.1165/rcmb.2022-0107TR.
4
Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review.全球新型冠状病毒病 2019(COVID-19)后状况或长新冠的流行率:一项荟萃分析和系统评价。
J Infect Dis. 2022 Nov 1;226(9):1593-1607. doi: 10.1093/infdis/jiac136.
5
Patterns of Inflammatory Cell Infiltration and Expression of STAT6 in the Lungs of Patients With COVID-19: An Autopsy Study.COVID-19 患者肺部炎症细胞浸润模式和 STAT6 表达:一项尸检研究。
Appl Immunohistochem Mol Morphol. 2022;30(5):350-357. doi: 10.1097/PAI.0000000000001023. Epub 2022 Apr 4.
6
ACE2 protein expression in lung tissues of severe COVID-19 infection.严重 COVID-19 感染肺组织中的 ACE2 蛋白表达。
Sci Rep. 2022 Mar 8;12(1):4058. doi: 10.1038/s41598-022-07918-6.
7
SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis.SARS-CoV-2 感染引发成纤维细胞增生性巨噬细胞反应和肺纤维化。
Cell. 2021 Dec 22;184(26):6243-6261.e27. doi: 10.1016/j.cell.2021.11.033. Epub 2021 Nov 27.
8
Peripheral innate and adaptive immune cells during COVID-19: Functional neutrophils, pro-inflammatory monocytes, and half-dead lymphocytes.COVID-19 期间的外周先天和适应性免疫细胞:功能失调的中性粒细胞、促炎单核细胞和濒死的淋巴细胞。
Cytometry B Clin Cytom. 2022 Mar;102(2):153-167. doi: 10.1002/cyto.b.22042. Epub 2021 Nov 30.
9
The evaluation of both the expression and serum protein levels of Caspase-3 gene in patients with different degrees of SARS-CoV2 infection.评估不同程度 SARS-CoV2 感染患者 Caspase-3 基因的表达和血清蛋白水平。
J Med Virol. 2022 Mar;94(3):897-905. doi: 10.1002/jmv.27362. Epub 2021 Oct 18.
10
Distinctive pseudopalisaded histiocytic hyperplasia characterizes the transition of exudative to proliferative phase of diffuse alveolar damage in patients dying of COVID-19.在因 COVID-19 而死亡的患者中,弥漫性肺泡损伤渗出期向增殖期的转变以独特的假栅状组织细胞增生为特征。
Hum Pathol. 2021 Oct;116:49-62. doi: 10.1016/j.humpath.2021.06.008. Epub 2021 Jul 14.